TR200002580T2 - Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler - Google Patents

Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler

Info

Publication number
TR200002580T2
TR200002580T2 TR2000/02580T TR200002580T TR200002580T2 TR 200002580 T2 TR200002580 T2 TR 200002580T2 TR 2000/02580 T TR2000/02580 T TR 2000/02580T TR 200002580 T TR200002580 T TR 200002580T TR 200002580 T2 TR200002580 T2 TR 200002580T2
Authority
TR
Turkey
Prior art keywords
substituted
bisindolimaleimides
cell proliferation
inhibit cell
methyl
Prior art date
Application number
TR2000/02580T
Other languages
English (en)
Inventor
Urvashi Dhingra Hooda
Donna Huryn Mary
Ke June
Giuseppe Weber Federico
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of TR200002580T2 publication Critical patent/TR200002580T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

R'1'in hidrojen, R2'nin ise metil veya R1'in metil, R'2'nin ise hidrojen veya R1'in hidroksimetil, R2'nin ise metil oldugu formül (I)'in ikameli pirolleri ve ayrica, bunlarin farmasötik açidan kabul görür ön ilaçlari veya farmasötik açidan kabul görür tuzlari, kanser tedavisinde yararli olan antiproliferatif maddelerdir.
TR2000/02580T 1998-03-17 1999-03-10 Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler TR200002580T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7833198P 1998-03-17 1998-03-17

Publications (1)

Publication Number Publication Date
TR200002580T2 true TR200002580T2 (tr) 2000-11-21

Family

ID=22143350

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02580T TR200002580T2 (tr) 1998-03-17 1999-03-10 Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler

Country Status (34)

Country Link
US (1) US6048887A (tr)
EP (1) EP1064279B1 (tr)
JP (2) JP5026633B2 (tr)
KR (1) KR100659411B1 (tr)
CN (1) CN1127500C (tr)
AR (1) AR018162A1 (tr)
AT (1) ATE243693T1 (tr)
AU (1) AU755673B2 (tr)
BR (1) BR9908882A (tr)
CA (1) CA2322689C (tr)
CO (1) CO5070675A1 (tr)
CZ (1) CZ299068B6 (tr)
DE (1) DE69909068T2 (tr)
DK (1) DK1064279T3 (tr)
ES (1) ES2203111T3 (tr)
HK (1) HK1036452A1 (tr)
HR (1) HRP20000585B1 (tr)
HU (1) HU228831B1 (tr)
ID (1) ID26353A (tr)
IL (1) IL138247A (tr)
MA (1) MA26613A1 (tr)
MY (1) MY121046A (tr)
NO (1) NO320306B1 (tr)
NZ (1) NZ506476A (tr)
PE (1) PE20000340A1 (tr)
PL (1) PL195323B1 (tr)
PT (1) PT1064279E (tr)
RS (1) RS49965B (tr)
RU (1) RU2208612C2 (tr)
SA (1) SA99191295B1 (tr)
TR (1) TR200002580T2 (tr)
TW (1) TW539676B (tr)
WO (1) WO1999047518A1 (tr)
ZA (1) ZA992072B (tr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1064279B1 (en) * 1998-03-17 2003-06-25 F.Hoffmann-La Roche Ag Substituted bisindolylmaleimides for the inhibition of cell proliferation
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
WO2001027106A1 (en) * 1999-10-12 2001-04-19 F. Hoffmann-La Roche Ag Substituted pyrroles as antiproliferative agents for the treatment of cancer
US6559164B1 (en) 1999-10-12 2003-05-06 Hoffmann-La Roche Inc. Substituted pyrroles suitable for continuous infusion
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
US6326501B1 (en) * 2000-04-19 2001-12-04 Hoffmann-La Roche Inc. Methylation of indole compounds using dimethyl carbonate
US7129250B2 (en) * 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
CA2308994A1 (en) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Neuroprotective compounds
US6469179B1 (en) 2000-10-03 2002-10-22 Hoffmann-La Roche Inc. Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
US6482847B2 (en) 2000-10-03 2002-11-19 Hoffmann-La Roche Inc. Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
US6548531B2 (en) 2001-02-09 2003-04-15 Hoffmann-La Roche Inc. Method for cancer therapy
WO2002102373A1 (en) * 2001-06-15 2002-12-27 F. Hoffmann-La Roche Ag Method for administration of cancer therapeutic
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
WO2008117935A1 (en) * 2007-03-28 2008-10-02 Industry-Academic Cooperation Foundation, Yonsei University Nk cell activating molecules, nk cells and pharmaceutical compositons comprising the same
CN102924437B (zh) * 2012-11-19 2014-07-02 东华大学 3-哌嗪基-4-吲哚马来酰亚胺化合物及其制备和应用
WO2019000224A1 (zh) * 2017-06-27 2019-01-03 中国海洋大学 双吲哚马来酰亚胺衍生物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK278989B6 (sk) * 1988-02-10 1998-05-06 F. Hoffmann-La Roche Ag Substituované pyroly, ich použitie na výrobu lieči
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DK0817627T3 (da) * 1993-12-23 2005-06-06 Lilly Co Eli Inhibitorer af proteinkinase C
PE91698A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91498A1 (es) * 1996-07-29 1998-12-22 Hoffmann La Roche Pirroles sustituidos
PE91598A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
EP1064279B1 (en) * 1998-03-17 2003-06-25 F.Hoffmann-La Roche Ag Substituted bisindolylmaleimides for the inhibition of cell proliferation

Also Published As

Publication number Publication date
PE20000340A1 (es) 2000-05-13
ATE243693T1 (de) 2003-07-15
MY121046A (en) 2005-12-30
ID26353A (id) 2000-12-14
DE69909068D1 (de) 2003-07-31
AU755673B2 (en) 2002-12-19
DK1064279T3 (da) 2003-10-06
NO20004579D0 (no) 2000-09-14
JP5026633B2 (ja) 2012-09-12
HUP0101258A2 (hu) 2001-10-28
NO320306B1 (no) 2005-11-21
CN1127500C (zh) 2003-11-12
AU3409999A (en) 1999-10-11
EP1064279B1 (en) 2003-06-25
AR018162A1 (es) 2001-10-31
BR9908882A (pt) 2000-11-21
MA26613A1 (fr) 2004-12-20
IL138247A (en) 2005-08-31
PT1064279E (pt) 2003-10-31
CA2322689A1 (en) 1999-09-23
JP2002506864A (ja) 2002-03-05
SA99191295B1 (ar) 2006-04-26
US6048887A (en) 2000-04-11
NZ506476A (en) 2003-12-19
ZA992072B (en) 1999-09-22
HU228831B1 (en) 2013-05-28
RS49965B (sr) 2008-09-29
TW539676B (en) 2003-07-01
IL138247A0 (en) 2001-10-31
YU55200A (sh) 2002-11-15
CN1293671A (zh) 2001-05-02
NO20004579L (no) 2000-09-14
EP1064279A1 (en) 2001-01-03
ES2203111T3 (es) 2004-04-01
WO1999047518A1 (en) 1999-09-23
HK1036452A1 (en) 2002-01-04
PL342964A1 (en) 2001-07-16
CZ20003384A3 (cs) 2000-12-13
KR100659411B1 (ko) 2006-12-18
HRP20000585B1 (en) 2009-02-28
CZ299068B6 (cs) 2008-04-16
CO5070675A1 (es) 2001-08-28
JP2010222366A (ja) 2010-10-07
RU2208612C2 (ru) 2003-07-20
KR20010041995A (ko) 2001-05-25
HUP0101258A3 (en) 2002-08-28
HRP20000585A2 (en) 2001-08-31
CA2322689C (en) 2008-11-25
PL195323B1 (pl) 2007-09-28
DE69909068T2 (de) 2004-05-06

Similar Documents

Publication Publication Date Title
TR200002580T2 (tr) Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler
DE60015927D1 (en) Phenylharnstoff und phenylthioharnstoffderivate
TR200000482T2 (tr) N-Aroilfenilalanin türevleri.
TR200101239T2 (tr) İkameli-2-fenilbenzimidazoller, üretimleri ve kullanımları
DE59709437D1 (de) Neue phenanthridine
TR199800436A2 (tr) Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
EE200000033A (et) Uudsed tetrasoolderivaadid
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
TR199900157T2 (tr) Hücre proliferasyon inhibisyonu için ikame edilmis bisindolilmaleimidleri.
TR200002605T2 (tr) Nitrik oksit sentaz inhibitörleri olarak faydalı halojene amidino amino asit türevleri
ATE258930T1 (de) Dihydrobenzifurane
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
TR200100133T2 (tr) FKBP İnhibitörleri
SE9504662D0 (sv) New compounds
TR199900153T2 (tr) Hücre çogalmasini önlemek için ikame edilmis bisindolilmaleimitler.
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
DK1244643T3 (da) Tryptaseinhibitorer
DK1244614T3 (da) Tryptase-inhibitorer
TR199801902A2 (tr) Sülfonamid ile sübstitüe edilmis kromanlar, bunlari içeren farmakolojik bilesimler.
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
TR199902117T2 (tr) (E)-4,6- Dikloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1H-Indol-2-karboksilik asidin kristalimsi hidratlanmis sodyum tuzu.
TR200100159T2 (tr) Antitrombotik maddeler olarak bispiperidinler